A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
·
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
OTHER
·

Directory Results for Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Treating patients suffering from EGFR mutant non-small cell lung cancer (NSCLC) with first-generation EGFR tyrosine kinase to Novel Semi-Rigid Capsule Insulation Demonstration. This effort probed the novel use of capsule insulation to an effective solid (as compared to powder) insulating blanket, panel, or other useful structures and to demonstrate important technical

Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Treating patients suffering from EGFR mutant non-small cell lung cancer (NSCLC) with first-generation EGFR tyrosine kinase
Novel Semi-Rigid Capsule Insulation Demonstration. This effort probed the novel use of capsule insulation to an effective solid (as compared to powder) insulating blanket, panel, or other useful structures and to demonstrate important technical